Demonstration Plans

Demonstration plans in insurance refer to programs or projects that are designed to test new healthcare delivery models, payment systems, or benefits structures. These plans are usually implemented for a limited period of time and involve a specific group of people, such as a certain population or group of healthcare providers. The aim of demonstration plans is to assess the effectiveness of new approaches to healthcare delivery and payment, and to identify ways to improve the quality and affordability of healthcare.

For example, a demonstration plan might involve testing a new payment model for healthcare providers, such as a bundled payment system where providers receive a fixed amount of money for a specific episode of care. The plan might be implemented for a certain group of providers, such as those who care for patients with chronic conditions, to assess whether the new payment model leads to better outcomes and lower costs.

Key features of demonstration plans include:

  • They are typically implemented for a limited period of time, such as a few years, to allow for evaluation and analysis of the results.
  • They are designed to test new healthcare delivery models, payment systems, or benefits structures, with the goal of improving the quality and affordability of healthcare.
  • They often involve a specific population or group of healthcare providers, such as those who care for patients with a certain condition or in a certain geographic area.
  • They are often funded by government agencies or private organizations with an interest in improving healthcare.
  • The results of demonstration plans can inform policy decisions and lead to changes in the healthcare system.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.